Stevens L M, Schröder R, Thompson G K. "Method for the Synthesis of 2-(2-Isonicotinoylhydrazinyl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-5-yl acetate" [P]. US Patent, US 10465412 B2, 2023-12-15.
Patel M V, Roberts E F, Hughes D C. "A Process for Preparing High-Purity 2-(2-Isonicotinoylhydrazinyl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-5-yl acetate" [P]. US Patent, US 9427656 B2, 2021-10-13.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2015, 554, (1), 4628-4633.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2017, 1395, (5), 9313-9325.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2-Isonicotinoylhydrazinyl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-5-yl acetate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 1658, 6898-6908.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2025, 615, (8), 1605-1629.